At EquiCord, we have been developing DogStem® since 2017: our medication for the treatment of canine osteoarthritis. DogStem® was unanimously approved by the EMA and the UK in mid-2022.
DogStem® contains 7.5 million equine umbilical cord stem cells as its active ingredient.
It is a veterinary prescription drug, designed to be ready to use, which can be stored in the veterinary clinics themselves in a refrigerator.
Pluripotent Mesenchymal Cells
Regenerative medicine without systemic adverse effects
Long-lasting clinical effect
Improved quality of life
Quality, safety and efficacy guaranteed by the EU
Ready-to-use product